about
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolismA novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growthNFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progressionThe role of c-Jun and c-Fos expression in androgen-independent prostate cancer.RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancerExpression of RUNX1 correlates with poor patient prognosis in triple negative breast cancerTamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk predictionThe relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancerPhosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancerBreast cancer patients' clinical outcome measures are associated with Src kinase family member expression.Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancerThe relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinomaThe androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancerSprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer.Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997.Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours.The in situ local immune response, tumour senescence and proliferation in colorectal cancer.Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerThe role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer.Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer.Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence.Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer.Senescent cells harbour features of the cancer epigenome.Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.Colorectal cancer subtypes: Translation to routine clinical pathology.Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesisNuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor.SRC family kinase activity is up-regulated in hormone-refractory prostate cancer.Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients.
P50
Q24305332-38B34D5A-AD9C-49B2-BBE9-0F8E1C2CE200Q28116222-B3609A8D-2BC0-45AC-AFE8-55AE27A27263Q28390763-CD580048-28DC-49B7-B959-FFA6C3562E7DQ31113642-CF3534C9-BEAC-4B55-A433-6C36D7B2AEB0Q33555996-6ACDBC29-6CC8-4E5B-A037-34DA78150250Q33779333-45E044B2-6E54-4C9D-8192-5E482B2B7E7BQ33812500-0388363F-F236-4E02-BEEC-9E301CD59464Q33847811-1C1CAE66-7514-4E92-94F6-1BDA484F9AE2Q33877484-0CF086AF-AD13-4A4D-9996-9AED5246A9E8Q33913872-E9CA2CD1-ED2B-4A93-8BC8-AC96A225ADBDQ34253693-6338F48D-7E1A-439E-A771-DA0D6E907AF0Q34253835-298921F7-1C61-4961-8F61-09AC6C57D57EQ35239611-6078754E-AF40-4685-8D5A-A08EB719ADFEQ35879893-FFAD1F2B-D881-46BE-971C-76C3E1E0BBA1Q36126914-0A4BB467-596B-4200-835F-2D08F771E8F5Q36295024-192932F5-DFB7-4125-A2C8-17BEA220CFA0Q36638098-CC33D4BF-644E-4D78-AB5A-75D326DBED57Q37010584-8D095452-606C-4EAC-8AAC-E691001B1C67Q37123512-427F34CE-D524-40B7-98EE-8E7DF55F6D02Q37123529-C3202718-CDD6-45C8-B128-2D707C182839Q37235543-D4A88C88-E0D1-49C0-9F12-8BA601E8C9D4Q37362042-EFB74058-7FC8-48B7-B9F0-EC7693016F7FQ37533025-BF012DC0-1BAE-4732-AB82-E9737BCD267AQ37730979-B525CDF5-3D72-4C51-ABCE-5D6E1D66F7F8Q38146062-6230C712-DDA9-4DAC-A41E-2BF67161FD21Q38407976-3BBE7CCB-CE3C-4588-A710-19E2506221F1Q38457224-6EB8708C-C6B7-4643-A55E-F14A78E9D02AQ38602735-BB0753C0-3BB4-402B-B1DF-7FEF7589F89FQ38724755-3AD82EA7-44B3-4634-A711-3CFE7AA483D1Q38825651-CC3E95B9-6761-4AAC-A403-F96FD3FCA5C8Q38945227-DB231A10-1B73-407C-98D2-174680C5665AQ38976198-C29E6C97-7C60-4614-A963-A3AE232EE72EQ39056256-50D93325-5B58-4397-AEA9-C74E9E092438Q39093621-860EB4B7-D1E5-4513-9951-5963E5ED746DQ39307158-3FD03392-5514-43DB-99A4-BB7F79C0DD98Q39329100-53DA3233-C731-48F9-A585-1E0DC551A4BBQ39339428-20B9796E-A429-48C0-B559-ABA9791DBE7CQ39642603-C8C09DBD-E078-47C6-86AD-0C3B4032762DQ39850321-BBB77E13-BC38-476E-9DAB-64E4F9664647Q40001031-7812E761-1518-4D13-B937-15F6BABB2462
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joanne Edwards
@ast
Joanne Edwards
@en
Joanne Edwards
@es
Joanne Edwards
@nl
Joanne Edwards
@sl
type
label
Joanne Edwards
@ast
Joanne Edwards
@en
Joanne Edwards
@es
Joanne Edwards
@nl
Joanne Edwards
@sl
prefLabel
Joanne Edwards
@ast
Joanne Edwards
@en
Joanne Edwards
@es
Joanne Edwards
@nl
Joanne Edwards
@sl
P1053
J-1903-2015
P106
P21
P31
P3829
P496
0000-0002-7192-6906